US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 2.220
  • +0.030+1.37%
Close Dec 20 16:00 ET
  • 2.220
  • 0.0000.00%
Post 16:03 ET
125.62MMarket Cap-1.67P/E (TTM)

Black Diamond Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-24.50%18.13M
10.47%22.13M
-6.10%20.25M
-6.86%86.46M
-4.56%20.86M
8.53%24.01M
-13.55%20.03M
-16.04%21.56M
-26.83%92.83M
-16.21%21.85M
Selling and administrative expenses
-33.62%5.22M
39.20%9.57M
-1.57%6.7M
-4.51%27.11M
-23.15%5.57M
25.19%7.86M
-1.43%6.88M
-13.75%6.81M
-5.50%28.39M
12.89%7.24M
-General and administrative expense
-33.62%5.22M
39.20%9.57M
-1.57%6.7M
-4.51%27.11M
-23.15%5.57M
25.19%7.86M
-1.43%6.88M
-13.75%6.81M
-5.50%28.39M
12.89%7.24M
Research and development costs
-20.06%12.91M
-4.55%12.56M
-8.19%13.55M
-7.89%59.35M
4.65%15.29M
1.94%16.15M
-18.78%13.15M
-17.05%14.75M
-33.45%64.44M
-25.71%14.61M
Operating profit
24.50%-18.13M
-10.47%-22.13M
6.10%-20.25M
6.86%-86.46M
4.56%-20.86M
-8.53%-24.01M
13.55%-20.03M
16.04%-21.56M
26.83%-92.83M
16.21%-21.85M
Net non-operating interest income expense
17.54%516K
-13.91%464K
2.41%637K
-5.27%1.92M
-52.14%324K
-21.89%439K
39.64%539K
53.20%622K
-41.37%2.03M
15.14%677K
Non-operating interest income
17.54%516K
-13.91%464K
2.41%637K
-5.27%1.92M
-52.14%324K
-21.89%439K
39.64%539K
53.20%622K
-41.37%2.03M
15.14%677K
Other net income (expense)
263.43%2.06M
415.25%1.76M
2,062.50%1.38M
662.90%2.09M
1,057.73%1.12M
715.22%566K
338.46%341K
127.35%64K
83.00%-372K
125.87%97K
Earnings from equity interest
----
----
----
--0
----
----
----
----
---2.25M
----
Special income (charges)
----
----
----
--0
----
----
----
----
--2.23M
----
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
--2.23M
----
Other non- operating income (expenses)
263.43%2.06M
415.25%1.76M
2,062.50%1.38M
691.53%2.09M
876.52%1.12M
715.22%566K
338.46%341K
127.35%64K
83.82%-354K
130.67%115K
Income before tax
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
27.41%-91.17M
18.51%-21.08M
Income tax
Net income
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
27.41%-91.17M
18.51%-21.08M
Net income continuous Operations
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
27.41%-91.17M
18.51%-21.08M
Minority interest income
Net income attributable to the parent company
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
27.41%-91.17M
18.51%-21.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
27.41%-91.17M
18.51%-21.08M
Basic earnings per share
37.78%-0.28
30.77%-0.36
38.60%-0.35
25.40%-1.88
42.37%-0.34
25.00%-0.45
17.46%-0.52
18.57%-0.57
27.38%-2.52
16.90%-0.59
Diluted earnings per share
37.78%-0.28
30.77%-0.36
38.60%-0.35
25.40%-1.88
42.37%-0.34
25.00%-0.45
17.46%-0.52
18.57%-0.57
27.38%-2.52
16.90%-0.59
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense -24.50%18.13M 10.47%22.13M -6.10%20.25M -6.86%86.46M -4.56%20.86M 8.53%24.01M -13.55%20.03M -16.04%21.56M -26.83%92.83M -16.21%21.85M
Selling and administrative expenses -33.62%5.22M 39.20%9.57M -1.57%6.7M -4.51%27.11M -23.15%5.57M 25.19%7.86M -1.43%6.88M -13.75%6.81M -5.50%28.39M 12.89%7.24M
-General and administrative expense -33.62%5.22M 39.20%9.57M -1.57%6.7M -4.51%27.11M -23.15%5.57M 25.19%7.86M -1.43%6.88M -13.75%6.81M -5.50%28.39M 12.89%7.24M
Research and development costs -20.06%12.91M -4.55%12.56M -8.19%13.55M -7.89%59.35M 4.65%15.29M 1.94%16.15M -18.78%13.15M -17.05%14.75M -33.45%64.44M -25.71%14.61M
Operating profit 24.50%-18.13M -10.47%-22.13M 6.10%-20.25M 6.86%-86.46M 4.56%-20.86M -8.53%-24.01M 13.55%-20.03M 16.04%-21.56M 26.83%-92.83M 16.21%-21.85M
Net non-operating interest income expense 17.54%516K -13.91%464K 2.41%637K -5.27%1.92M -52.14%324K -21.89%439K 39.64%539K 53.20%622K -41.37%2.03M 15.14%677K
Non-operating interest income 17.54%516K -13.91%464K 2.41%637K -5.27%1.92M -52.14%324K -21.89%439K 39.64%539K 53.20%622K -41.37%2.03M 15.14%677K
Other net income (expense) 263.43%2.06M 415.25%1.76M 2,062.50%1.38M 662.90%2.09M 1,057.73%1.12M 715.22%566K 338.46%341K 127.35%64K 83.00%-372K 125.87%97K
Earnings from equity interest ---- ---- ---- --0 ---- ---- ---- ---- ---2.25M ----
Special income (charges) ---- ---- ---- --0 ---- ---- ---- ---- --2.23M ----
-Gain on sale of property,plant,equipment ---- ---- ---- --0 ---- ---- ---- ---- --2.23M ----
Other non- operating income (expenses) 263.43%2.06M 415.25%1.76M 2,062.50%1.38M 691.53%2.09M 876.52%1.12M 715.22%566K 338.46%341K 127.35%64K 83.82%-354K 130.67%115K
Income before tax 32.38%-15.56M -3.95%-19.91M 12.69%-18.23M 9.57%-82.44M 7.92%-19.41M -6.25%-23.01M 16.48%-19.15M 18.16%-20.88M 27.41%-91.17M 18.51%-21.08M
Income tax
Net income 32.38%-15.56M -3.95%-19.91M 12.69%-18.23M 9.57%-82.44M 7.92%-19.41M -6.25%-23.01M 16.48%-19.15M 18.16%-20.88M 27.41%-91.17M 18.51%-21.08M
Net income continuous Operations 32.38%-15.56M -3.95%-19.91M 12.69%-18.23M 9.57%-82.44M 7.92%-19.41M -6.25%-23.01M 16.48%-19.15M 18.16%-20.88M 27.41%-91.17M 18.51%-21.08M
Minority interest income
Net income attributable to the parent company 32.38%-15.56M -3.95%-19.91M 12.69%-18.23M 9.57%-82.44M 7.92%-19.41M -6.25%-23.01M 16.48%-19.15M 18.16%-20.88M 27.41%-91.17M 18.51%-21.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.38%-15.56M -3.95%-19.91M 12.69%-18.23M 9.57%-82.44M 7.92%-19.41M -6.25%-23.01M 16.48%-19.15M 18.16%-20.88M 27.41%-91.17M 18.51%-21.08M
Basic earnings per share 37.78%-0.28 30.77%-0.36 38.60%-0.35 25.40%-1.88 42.37%-0.34 25.00%-0.45 17.46%-0.52 18.57%-0.57 27.38%-2.52 16.90%-0.59
Diluted earnings per share 37.78%-0.28 30.77%-0.36 38.60%-0.35 25.40%-1.88 42.37%-0.34 25.00%-0.45 17.46%-0.52 18.57%-0.57 27.38%-2.52 16.90%-0.59
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List